{
  "_links": {
    "priorVersion": {
      "href": "/mdr/ct/packages/protocolct-2020-12-18",
      "title": "Protocol Controlled Terminology Package 44 Effective 2020-12-18",
      "type": "Terminology"
    },
    "self": {
      "href": "/mdr/ct/packages/protocolct-2021-03-26",
      "title": "Protocol Controlled Terminology Package 45 Effective 2021-03-26",
      "type": "Terminology"
    }
  },
  "codelists": [
    {
      "conceptId": "C139020",
      "definition": "A terminology value set relevant to the attributes of the clinical trial entity.",
      "name": "Clinical Trial Attribute Terminology",
      "preferredTerm": "CDISC Protocol Entities Clinical Trial Attribute Terminology",
      "submissionValue": "Clinical Trial Attribute Terminology",
      "synonyms": [
        "Clinical Trial Attribute Terminology"
      ],
      "terms": [
        {
          "conceptId": "C85826",
          "definition": "The principal purpose of the trial.",
          "preferredTerm": "Trial Primary Objective",
          "submissionValue": "Trial Primary Objective",
          "synonyms": [
            "Trial Primary Objective"
          ]
        }
      ]
    }
  ],
  "description": "CDISC Controlled Terminology for Protocol is the set of CDISC-developed or CDISC-adopted standard expressions (values) used with data items within CDISC-defined PROTOCOL datasets.",
  "effectiveDate": "2021-03-26",
  "label": "Protocol Controlled Terminology Package 45 Effective 2021-03-26",
  "name": "Protocol CT 2021-03-26",
  "registrationStatus": "Final",
  "source": "Protocol Controlled Terminology developed by the CDISC Terminology Team in collaboration with the National Cancer Institute's Enterprise Vocabulary Services (EVS)",
  "version": "2021-03-26"
}